Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Kubicka

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 5, 2014
[Radiotherapy of bulky disease after completion of chemotherapy improves immune outcome of elderly patients with aggressive B-cell lymphoma. ]Stefan Kubicka
The Lancet. Oncology|September 14, 2013
Low-toxicity treatment for colorectal cancer in elderly peopleStefan Kubicka
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 9, 2016
[Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial]Stefan Kubicka
MMW Fortschritte Der Medizin|February 16, 2021
[Treating lung cancer in primary care]Adrian Gillissen, Stefan Kubicka
Gastroenterology|August 12, 2008
Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models?Lars Zender, Stefan Kubicka
Onkologie|October 16, 2008
Molecular pathogenesis and targeted therapy of hepatocellular carcinomaLars Zender, Stefan Kubicka
Hepatology (Baltimore, Md.)|October 31, 2008
Reshaping AAV vectors for liver gene therapyFlorian Kühnel, Stefan Kubicka
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAsLars Zender, Stefan Kubicka
Oncoimmunology|June 22, 2012
Virus infections in tumors pave the way for tumor-directed DC-vaccinesNorman Woller, Florian Kühnel, Stefan Kubicka
Current Molecular Medicine|June 25, 2005
Telomerase-dependent gene therapyThomas Wirth, Florian Kühnel, Stefan Kubicka
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 5, 2014
[Radiotherapy of bulky disease after completion of chemotherapy improves immune outcome of elderly patients with aggressive B-cell lymphoma. ]Stefan Kubicka
The Lancet. Oncology|September 14, 2013
Low-toxicity treatment for colorectal cancer in elderly peopleStefan Kubicka
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 9, 2016
[Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial]Stefan Kubicka
MMW Fortschritte Der Medizin|February 16, 2021
[Treating lung cancer in primary care]Adrian Gillissen, Stefan Kubicka
Gastroenterology|August 12, 2008
Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models?Lars Zender, Stefan Kubicka
Onkologie|October 16, 2008
Molecular pathogenesis and targeted therapy of hepatocellular carcinomaLars Zender, Stefan Kubicka
Hepatology (Baltimore, Md.)|October 31, 2008
Reshaping AAV vectors for liver gene therapyFlorian Kühnel, Stefan Kubicka
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAsLars Zender, Stefan Kubicka
Oncoimmunology|June 22, 2012
Virus infections in tumors pave the way for tumor-directed DC-vaccinesNorman Woller, Florian Kühnel, Stefan Kubicka
Current Molecular Medicine|June 25, 2005
Telomerase-dependent gene therapyThomas Wirth, Florian Kühnel, Stefan Kubicka
Pageof 9